Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab
- PMID: 15014320
- DOI: 10.1097/01.inf.0000121203.33560.f9
Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab
Comment on
-
Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease?Pediatr Infect Dis J. 2003 Nov;22(11):939-43. doi: 10.1097/01.inf.0000095300.31563.f7. Pediatr Infect Dis J. 2003. PMID: 14614363
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical